Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Carmona-Bayonas A, Alvarez-Escola C, Ballester Navarro I, Hernando Cubero J, Mangas Cruz MA, Garcia-Centeno R, Iglesias C, Garcia-Donas J, Picon MJ, Paja M, Gonzalez Batanero L, Garcia L, Alonso Gordoa T, Lopez C, Hanzu F, Martinez-Trufero J, Febrero B, Saiz-Lopez P, Blanco Carrera C, Ramon Y Cajal T, Veiguela B, Gressani O, Valdes N, Jimenez-Fonseca P. Does Adjuvant Mitotane Impact Cure Rates in Adrenocortical Carcinoma? Insights From the ICARO-GETTHI/SEEN Registry. J Clin Endocrinol Metab. 2025 Oct 16;110(11):3155-3167. doi: 10.1210/clinem/dgaf082. PubMed PMID: 39988973.
AÑO: 2025; IF: 5.1
39988973
Obispo B, Calderon C, Carmona-Bayonas A, Ghanem I, Cano-Cano JM, Jimenez-Fonseca P. The role of baseline and persistent depression in adjuvant cancer therapy: impact on toxicity and quality of life. Int J Clin Health Psychol. 2025 Oct-Dec;25(4):100640. doi: 10.1016/j.ijchp.2025.100640. Epub 2025 Oct 17. PubMed PMID: 41146968; PubMed Central PMCID: PMC12554112.
AÑO: 2025; IF: 4.4
41146968
Jimenez-Vicente C, Beneit P, Cano-Ferri I, Merchan B, Arnan M, Guinon AG, Martinez-Bilbao C, Alfonso A, Martinez-Sanchez P, Alonso-Dominguez JM, Lopez-Godino O, Castano-Diez S, Zugasti I, Esteve J, Diaz-Beya M, de la Fuente A. Enasidenib as treatment for AML with IDH2 mutation: multicenter real-life study of the early-access program in Spain. Ann Hematol. 2025 Sep;104(9):4863-4871. doi: 10.1007/s00277-025-06464-1. Epub 2025 Jul 12. PubMed PMID: 40650712; PubMed Central PMCID: PMC12552362.
AÑO: 2025; IF: 2.4
40650712
Kruijt M, de la Morena-Barrio ME, Corral J, Cobbaert CM, Ruhaak LR. Novel insights into antithrombin deficiency enabled by mass spectrometry-based precision diagnostics. J Thromb Haemost. 2025 Jan;23(1):210-221. doi: 10.1016/j.jtha.2024.10.005. Epub 2024 Oct 17. PubMed PMID: 39423957.
AÑO: 2025; IF: 5.0
39423957
Moulis G, Chen F, Carli G, Ghanima W, Trautmann-Grill K, Stauch T, Schifferli A, Miah H, Rueter M, Ghiotto L, Tomasello R, Georgi A, McDonald V, Zaja F, Pettersen HH, Kuhne T, Lozano ML, Gonzalez-Lopez TJ, Provan D, Michel M, Cooper N, Rodeghiero F. Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registries. Haematologica. 2025 Jun 26. doi: 10.3324/haematol.2025.287408. Online ahead of print. PubMed PMID: 40568720.
AÑO: 2025; IF: 7.9
40568720
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL